Tenuta Liliana Vineyard Opens Up to Popular Shareholding on CrowdFundMe
The newly built winery of Tenuta Liliana was created inside a former tuff quarry, reclaimed and completely regenerated, and houses the most modern and technological machinery, essential to achieve qualitative excellence in production. A crowdfunding campaign was recently launched by its founders on CrowdFundMe.
Tenuta Liliana, the Salento winery founded by Antonio Intiglietta, President of Ge.Fi. Management Fairs and creator of Artigiano in Fiera, and his wife Liliana Angelillo, launches a crowdfunding campaign on CrowdFundMe to open the company structure to all those who want to participate in the regeneration project of land, a reference point for international and rich tourism of history and potential for excellence agriculture.
Each shareholder, with a free subscription from the minimum threshold of $262 (€250), will be able to participate in the operating profits of the winery, get a discount on the purchase of Tenuta Liliana bottles, take part in the sale of 1,000 bottles of the limited edition “Ladame” 2021 wine aged in tonneau for more than 12 months, share the experience of winery visits and tastings, including the most historic vintages that will enrich the estate’s heritage.
Get comprehensive access to global crowdfunding business, stock market, finance news, and trending topics with the Born2Invest companion app.
“Sharing has always been the keystone of our project,” explains founder Antonio Intiglietta
“Today Tenuta Liliana, which aims to produce a unique and excellent Cabernet Sauvignon in one of the most beautiful territories in our country, is a share company of 10 partners, to be joined by another 16 by the end of the year, from the United States, Europe, Asia, and Italy. The crowdfunding campaign is a new piece that aims to make even more protagonists of our proposal who have taken an interest in the project in recent years and all those who would like to contribute to the agricultural regeneration of Salento.”
Tenuta Liliana’s vineyards, in the “terroirs” selected by Frenchman Pierre Marie Guillaime, a world leader in the vine rootstock market, and winemaker Andrea Fattizzo, rise up to two hundred meters above sea level, strongly rooted in a land of ancient farming tradition. From the foundation to the present, 12.5 hectares of vines have been planted, in four different areas intended for the production of a specific estate wine based on Cabernet Sauvignon. The result is four types of organic wine, able precisely to express the different terroirs with the same grape variety, declined with geological and climatic differences.
In 2021 the first 7,000 bottles were produced, while starting in 2025 production will be limited to 75,000 bottles per year, to which will be added about 4,000 bottles of an Orange Wine, unique in style and taste in the Salento area. The newly built winery was created inside a former tuff quarry, reclaimed and
completely regenerated, and houses the most modern and technological machinery, essential to achieve qualitative excellence in production.
(Featured image by koreafreund via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in avvinando, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The TopRanked.io Weekly Digest: What’s Hot in Affiliate Marketing [Week 22]
This week we're waking the dead as we go back to the metaverse baby. With Apple soon announcing its long-awaited...
Bullish on Bitcoin? – Blackrock CEO Warns of “Debt Ceiling Drama”
Many bitcoin and cryptocurrency investor advocates view BTC as a hedge against inflation and debt concerns, especially as central banks...
Docline Prepares a New Round of 6 Million for 2024
Docline maintains an agreement with Mapfre, with whom it offers digital health programs to the company's policyholders; with the Ballesol retirement...
Cedacri Prices New €275M Bond to Pay €50M Tax and €150M Extra Dividend
As stated in the Report to Cedacri's 2022 Annual Report, and as recalled in the release in which Moody's assigned...
Bierzo Aire Limpio Starts Crowdfunding to Support the Legal Defense of the Environment
The NGO holds an assembly that includes a state-wide meeting against waste incineration, debates on wind and solar macro-projects, and...
Featured2 weeks ago
Coffee Producers in Vietnam and Indonesia Are Said to Have Almost Nothing Left to Sell
Biotech2 days ago
Sicit Acquires 51% of Plant Biostimulants from Chile’s Patagonia Biotechnology
Cannabis1 week ago
Where Do Cannabis Users Buy Cannabis From: New Frontier Data Study
Biotech2 weeks ago
Boehringer Ingelheim Invests 46 Million in R&D in 2022 in Spain